Circulating immune complexes and C3 in patients with systemic lupus erythematosus. the relationship between clinical manifestations and nephropathy
Rodríguez-Valverde, V.; Peña Sagredo, J.L.; Orte Martínez, J.; Novo Fernández, M.J.; Sánchez Andrada, S.; Sampedro Alvarez, J.
Medicina Clinica 78(9): 353-357
1982
ISSN/ISBN: 0025-7753 PMID: 6808263 Document Number: 184688
Document emailed within 1 workday
Related Documents
Davis, P.; Cumming, R.H.; Verrier-Jones, J. 1977: Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus Clinical and Experimental Immunology 28(2): 226-232Ternovoĭ, K.S.; Gandzha, I.M.; Babynina, L.I.; Volobueva, Z.V.; Sukharenko, N.V.; Dibrova, T.N.; Selezneva, T.N.; Ermekova, V.M. 1990: The levels of circulating immune complexes and immunoglobulins in patients with systemic lupus erythematosus and rheumatoid arthritis Vrachebnoe Delo 4: 48-50
Font, J.; Cardellach, F.; Mirapeix, E.; Martorell, J.; Ingelmo, M. 1982: Circulating immune complexes in systemic lupus erythematosus Medicina Clinica 79(10): 478
Moyito, T.; Aotsuka, S.; Yokohari, R.; Moroi, Y.; Yokohari, R. 1976: Clinical application of Fc-rosette. 1. Inhibition of Fc-rosette formation by systemic lupus erythematosus sera. a method for detection of circulating immune complexes Ryumachi 16(1): 4-11
Muso, E.; Yoshida, H.; Sekita, K.; Konishi, N.; Tamura, T.; Kanatsu, K.; Kawai, C.; Hamashima, Y. 1987: Immunopathological correlations of circulating immune complexes and anti-DNA antibodies to glomerular lesions in systemic lupus erythematosus Nihon Jinzo Gakkai Shi 29(5): 501-509
Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222
Okubo, Y. 1991: Analysis of components of immune complexes in sera of patients with systemic lupus erythematosus Ryumachi 31(1): 36-44
Morimoto, C.; Sano, H.; Abe, T.; Homma, M.; Steinberg, A.D. 1982: Correlation between clinical activity of systemic lupus erythematosus and the amounts of DNA in DNA/anti-DNA antibody immune complexes Journal of Immunology 129(5): 1960-1965
Serban, M.G. 1992: Circulating immune complexes and the complements system in lupus nephropathy Romanian Journal of Internal Medicine 30(2): 119-125
Zeng, F-qin.; Yin, R-fei.; Tan, G-zhen.; Guo, Q.; Xu, D-qing. 2004: Characterization of DNA antigens from immune complexes deposited in the skin of patients with systemic lupus erythematosus Chinese Medical Journal 117(7): 1066-1071
Adu, D.; Dobson, J.; Williams, D.G. 1981: DNA-anti-DNA circulating complexes in the nephritis of systemic lupus erythematosus Clinical and Experimental Immunology 43(3): 605-614
Rauch, J.; Hazeltine, M.; Tannenbaum, H.; Danoff, D.; Isenberg, D.A.; Wild, J.; Sampalis, J.; Esdaile, J.M. 1990: Association of anti-DNA idiotype markers with clinical and serological manifestations in patients with systemic lupus erythematosus Journal of Rheumatology 17(2): 178-185
Gluhovschi, G.; Trandafirescu, V.; Solovan, C.; Lazăr, E.; Gluhovschi, C.; Petrica, L.; Bob, F.; Bozdog, G.; Gadalean, F.; Cornianu, M.; Velciov, S. 2012: Has the diversity of clinical and biological manifestations of systemic lupus erythematosus a correspondent in the diversity of immune mechanisms? Observations based on a Rowell's syndrome case associated with arthritis and nephritis Romanian Journal of Internal Medicine 50(3): 249-255
El-Garf, A.; Salah, S.; Shaarawy, M.; Zaki, S.; Anwer, S. 1996: Prolactin hormone in juvenile systemic lupus erythematosus: a possible relationship to disease activity and CNS manifestations Journal of Rheumatology 23(2): 374-377
Halla, J.T.; Schrohenloher, R.E.; Volanakis, J.E. 1980: Immune complexes and other laboratory features of pleural effusions: a comparison of rheumatoid arthritis, systemic lupus erythematosus, and other diseases Annals of Internal Medicine 92(6): 748-752
Pradhan, V.; Surve, P.; Rajadhyaksha, A.; Rajendran, V.; Patwardhan, M.; Umare, V.; Ghosh, K.; Nadkarni, A. 2015: Mannose binding lectin (MBL) 2 gene polymorphism & its association with clinical manifestations in systemic lupus erythematosus (SLE) patients from western India Indian Journal of Medical Research 141(2): 199-204
Cairns, S.A.; London, A.; Mallick, N.P. 1980: The value of three immune complex assays in the management of systemic lupus erythematosus: an assessment of immune complex levels, size and immunochemical properties in relation to disease activity and manifestations Clinical and Experimental Immunology 40(2): 273-282
Tam, L-Shan.; Wong, A.; Mok, V.C.T.; Zhu, Y-Er.; Kwok, L-Wa.; Li, T.K.; Wong, K-Chiu.; Li, E.K. 2008: The relationship between neuropsychiatric, clinical, and laboratory variables and quality of life of Chinese patients with systemic lupus erythematosus Journal of Rheumatology 35(6): 1038-1045
Ward, M.M.; Studenski, S. 1990: Age associated clinical manifestations of systemic lupus erythematosus: a multivariate regression analysis Journal of Rheumatology 17(4): 476-481
Zech, P.; Richard, P.; Blanc-Brunat, N.; Labeeuw, M.; Colon, S.; Pozet, N.; Dupont, E.; Fries, D.; Traeger, J. 1972: Course of nephropathy in systemic lupus erythematosus . Influence of the treatment on clinical symptoms, renal function and histology Journal d'Urologie et de Nephrologie 78(12): 987-993